middle.news
Memphasys backs Felix growth with A$3.5 million shareholder funding
9:44am on Tuesday 29th of September, 2026 AEST
•
Biotechnology
Read Story
Memphasys backs Felix growth with A$3.5 million shareholder funding
9:44am on Tuesday 29th of September, 2026 AEST
Key Points
A$3.5 million interest-bearing advance due on 2 October
More than A$5.1 million in minimum contracted sales across 31 countries
Convertible notes could add 875 million shares before consolidation
One-for-ten share consolidation proposed for shareholder approval
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Memphasys (ASX:MEM)
OPEN ARTICLE